Steering Board

Equally representing the sites of Munich, Münster and the Rhine-Main Neuroscience Network (rmn2), the role of the Steering Board is to – amongst other things – coordinate the needs of the individual research groups; examine membership applications; and present project and funding requests to the DFG on behalf of the CRC.

 

Prof. Dr. Heinz Wiendl Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl (Münster), Spokesperson
Klinik für Neurologie
Universitätsklinikum der
Westfälischen Wilhelms-Universität Münster
E-Mail: heinz.wiendl@ukmuenster.de

 

 

 

Prof. Dr. Frauke ZippUniv-Prof. Dr. med. Frauke Zipp (rmn2), Co-Spokesperson
Klinik und Poliklinik für Neurologie
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: frauke.zipp@unimedizin-mainz.de

 

 

 

Prof. Martin Kerschensteiner width=Prof. Dr. Martin Kerschensteiner, Secretary
Institut für klinische Neuroimmunologie
Ludwig-Maximilians-Universität München
E-Mail: martin.kerschensteiner@med.uni-muenchen.de

 

 

 

 

Prof. Dr. Thomas Korn Prof. Dr. Thomas Korn
Neurologische Klinik und Poliklinik
Klinikum Rechts der Isar
Technische Universität München
E-Mail: thomas.korn@tum.de

 

 

 

Prof. Lydia Sorokin, PhDUniv.-Prof. Dr. rer. nat. Lydia Sorokin
Institut für Physiologische Chemie und Pathobiochemie
Westfälische Wilhelms-Universität Münster
E-Mail: sorokin@uni-muenster.de

 

 

 

 

Prof. Ari Waisman, PhD Univ.-Prof. Dr. rer. nat. Ari Waisman, PhD
Institut für Molekulare Medizin,
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: waisman@uni-mainz.de

News

Thu, 29/08/2019
Symposium: Multiple Sclerosis: balancing effector and regenerative pathways
The International Symposium of the Collaborative Research Centre 128 “Multiple Sclerosis” will take place from 08:30 on Monday 16th until 14:00 on Tuesday 17th September, 2019 at the University Medical Center in Mainz and will end with a general assembly for SFB members. A full program for the meeting can be found here....more
Mon, 03/06/2019
Publication: Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
Muenster. For the first time scientists from the University of Münster could show that multiple sclerosis (MS) alters the energy metabolism of T cells during acute phases of disease exacerbation. Therapeutic interventions targeting the metabolism of activated T cells display new potential avenues for treatment of patients with MS affecting around 250,000 people in Germany. The […]...more
Mon, 29/04/2019
Publication: Calcium influx through plasma-membrane nanoruptures drives axon degeneration in a model of multiple sclerosis.
Munich.  Here SFB researchers from Munich use in vivo calcium imaging in a multiple sclerosis model to show that cytoplasmic calcium levels determine the choice between axon loss and survival. Calcium can enter the axon through nanoscale ruptures of the axonal plasma membrane that are induced in inflammatory lesions. Neuron doi: 10.1016/ j.neuron.2018.12.023...more